Spatiotemporal Uptake Characteristics of [18]F-2-Fluoro-2-Deoxy-D-Glucose in a Rat Middle Cerebral Artery Occlusion Model by Yuan, Hong et al.
Spatiotemporal Uptake Characteristics of [18]F-2-Fluoro-2-Deoxy-
D-Glucose in a Rat Middle Cerebral Artery Occlusion Model
Hong Yuan, PhD, Jonathan E. Frank, MS, Yonglong Hong, MD, Hongyu An, DSc, Cihat
Eldeniz, BS, Jingxin Nie, PhD, Adomas Bunevicius, MD, PhD, Dinggang Shen, PhD, and
Weili Lin, PhD
Departments of Radiology (H.Y., H.A., J.N., D.S., W.L.) and Biomedical Engineering (C.E., W.L.),
Biomedical Research Imaging Center (H.Y., J.E.F., Y.H., H.A., J.N., A.B., D.S., W.L.), University
of North Carolina at Chapel Hill, NC
Abstract
Background and Purpose—Alterations of cerebral glucose metabolism are well anticipated
during cerebral ischemia. However, detailed spatiotemporal characteristics of disturbed cerebral
glucose metabolism during acute ischemia remain largely elusive. This study aims to delineate
spatiotemporal distributions of [18]F-2-fluoro-2-deoxy-D-glucose (FDG) uptake using positron
emission tomography imaging, particularly at the peri-ischemic zone, and its correlation with
tissue outcome.
Methods—The intraluminal suture middle cerebral artery occlusion model was used to induce
focal cerebral ischemia in rats (n=48). All animals underwent sequential MRI and FDG positron
emission tomography imaging at different times (30–150 minutes) after middle cerebral artery
occlusion. MR and positron emission tomography images were coregistered. FDG uptake in the
peri-ischemic zone was assessed in relation to middle cerebral artery occlusion duration, cerebral
blood flow, apparent diffusion coefficient, and 24-hour T2 lesions.
Results—Elevated FDG uptake was consistently observed at the peri-ischemic zone surrounding
the presumed ischemic core with low FDG uptake. Both the spatial volume and the uptake level of
the hyper-uptake region were inversely correlated with the duration of middle cerebral artery
occlusion. The hyper-uptake regions exhibited a mild reduction of cerebral blood flow
(28.2±3.2%) and apparent diffusion coefficient (9.1±1.4%) when compared with that in the
contralateral hemisphere. Colocalization analysis revealed that, with reperfusion, an average of
12.1±1.7% of the hyper-uptake volume was recruited into final infarction.
Conclusions—Elevated FDG uptake at the peri-ischemic zone is consistently observed during
acute cerebral ischemia. The region with elevated FDG uptake likely reflects viable tissues that
can be salvaged with reperfusion. Therefore, acute FDG positron emission tomography imaging
might hold promise in the management of patients with acute stroke.
Keywords
acute ischemic stroke; cerebral glucose metabolism; FDG PET
© 2013 American Heart Association, Inc.








Stroke. Author manuscript; available in PMC 2014 January 08.
Published in final edited form as:













During cerebral ischemia, reduction of cerebral blood flow (CBF) directly results in
concurrent reduction of oxygen and glucose supply to the brain, which in turn leads to
disturbed glucose metabolism and subsequent cellular dysfunctions attributed by the loss of
ATP.1,2 Depending on the extent to which CBF is reduced, alternations of glucose
metabolism could vary both spatially and temporally. Specifically, it has been widely and
consistently reported that glucose metabolism is greatly suppressed in the ischemic core
because of severe flow reduction in animals and patients with stroke using either 14C-2-
deoxyglucose autoradiography3,4 or positron emission tomography (PET) imaging with
[18]F-2-fluoro-2-deoxy-D-glucose (FDG).5,6 In contrast, results on the spatial and temporal
patterns of glucose metabolism in regions with moderate CBF reduction are somewhat
inconsistent. Using autoradiography, increased glucose uptake was observed near the
ischemic border 30 minutes and 1 hour after middle cerebral artery occlusion (MCAO) in
animals.3,7 However, Belayev et al8 reported a heterogeneous distribution of usage of
glucose in the peri-ischemic zone with sporadic loci of focally elevated or depressed glucose
uptake 2 hours after MCAO in a rat ischemic stroke model. As a result, no significant
quantitative changes were observed in glucose metabolism between the 2 hemispheres.
Using PET, an increased uptake of FDG in regions with mild reduction of CBF was also
reported in rats 75 minutes after MCAO.9 However, this hyper-uptake pattern no longer
existed 3 hours after MCAO in another study.10 Nasu et al11 imaged patients with stroke 1
to 7 days after cerebral ischemia using FDG PET, and hyper-accumulation of FDG was
observed around the depressed uptake core in 7 of 20 patients. Collectively, although
severely diminished glucose metabolism is consistently observed in ischemic core,
characteristics of glucose uptake at the peri-ischemic zone remain controversial. Although
several factors, including species, MCAO models, and imaging analysis approaches might
contribute to the reported inconsistent FDG uptake patterns at the peri-ischemic regions, one
of the most plausible explanations may be the different time intervals between the onset of
MCAO and time of glucose metabolism assay or FDG PET imaging. Furthermore, studies
investigating quantitative association between FDG hyper-uptake and final tissue outcome
are lacking. To this end, this study aimed to characterize spatiotemporal glucose uptake
patterns during acute cerebral ischemia using FDG PET in a rat MCAO model. Time
intervals between FDG injection and onset of MCAO were varied ranging from 30 to 150
minutes after MCAO. FDG uptake in the peri-ischemic zone was assessed in relation to
MCAO duration, CBF, and apparent diffusion coefficient (ADC) for all animals, and to 24-
hour T2 lesions for reperfused animals. Delineation of the spatiotemporal characteristics of
FDG uptake during acute ischemia may offer insights into dynamic alterations of glucose
metabolism, which may shed light on tissue viability.
Methods
A total of 48 male Long Evans rats (Charles River, Wilmington, MA) weighing between
250 and 350 g were included. All animal protocols were approved by the Institutional
Animal Care and Use Committee. Animals were divided into 5 groups on the basis of when
FDG was injected in relation to MCAO onset time, including 30 (n=5), 60 (n=13), 90
(n=13), 120 (n=12), and 150 minutes (n=5) after MCAO. MRI were acquired first followed
by PET imaging. A subset of animals (n=20) underwent reperfusion procedures (reperfusion
subgroup hereafter) immediately after PET imaging to discern the potential relation between
FDG uptake and final tissue fate. All the remaining animals not included in the reperfusion
subgroup were euthanized for autoradiography. In the reperfusion subgroup, animals were
again divided into 4 groups depending on when FDG was given, including 30, 60, 90, and
120 minutes after MCAO (n=5 for each subgroup). Reperfusion was accomplished
immediately after 40-minute PET scans resulting in a MCAO duration of 70, 100, 130, and
160 minutes, respectively. Animals were MR imaged 24 hours after MCAO and were
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euthanized after MRI. Detailed experimental protocols are provided in Figure I in the
online-only Data Supplement.
Surgical Procedures
The intraluminal MCAO method was adopted to induce focal cerebral ischemia.12 The
suture was placed into the internal carotid artery via the external carotid artery stump and
advanced for ≈21 mm until resistance was felt. For reperfusion, anesthesia was briefly
discontinued when animals were transported from the PET scanner to the surgical table
where isoflurane anesthesia was restored. Reperfusion was accomplished by withdrawing
the suture from the internal carotid artery to the external carotid artery to restore blood flow.
More information is provided in Surgical Procedures in the online-only Data Supplement.
Imaging
MRI were acquired using a Bruker 9.4T scanner (BioSpec 94/30; Bruker BioSpin, Inc,
Billerica, MA) and a phased array surface coil. T1-weighted, T2-weighted (T2w), and echo
planar imaging diffusion-weighted images were acquired and ADC maps were calculated.
The dynamic susceptibility contrast approach using a single-shot echo planar imaging
sequence was used and a singular value decomposition method was used for obtaining CBF
maps.13 All imaging parameters are provided in the online-only Data Supplement.
FDG PET imaging was performed using a small animal PET/computed tomography (CT)
scanner (Vista eXplore, GE Healthcare, Inc) with a center resolution of 1.2- and 46-mm
axial field of view.14 A 7-minute CT scan was first acquired for subsequent attenuation
correction and anatomic registration. FDG (39.4±8.2 MBq) diluted in saline was injected via
the tail vein at the predefined time after MCAO. With the exception of the 30-minute group,
dynamic PET acquisition was performed for 40 minutes (Figure I in the online-only Data
Supplement). The list-mode PET data were binned 3×10, 3×30, 1×180, 3×300, and 2×600 s.
For the 30-minute group, FDG was injected during MRI, and PET images were acquired for
10 minutes using the static acquisition mode. Data were reconstructed using the 2-
dimensional ordered subset expectation–maximization algorithm with random, scatter, and
attenuation correction.
Autoradiography
With the exception of the animals in the reperfusion subgroup, animals were euthanized
after PET (Figure I in the online-only Data Supplement) and brain tissues were collected and
snap-frozen in liquid nitrogen. Three coronal sections of 14 μm thickness were cut at 4, 5,
and 6 mm below the brain anterior apex. Six of 28 animals had poor cutting qualities
(wrinkles and tissue lost, etc.) and were excluded from the final analyses (more information
is provided in Autoradiography in the online-only Data Supplement).
Image Analysis
All MRI from the same animals were first registered using the FLIRT15 in FSK 3.2
(FMRIB, Oxford, United Kingdom). Skull bone structure was extracted from CT images
using a threshold method. T1-weighted MRI were bias corrected and Hessian matrix filtered
for sheet-like structure detection16 to extract bony structures. The CT and MR bone images
were registered using a rigid-body registration scheme. The transformation matrices were
subsequently used to register all MRI onto CT images. PET images were registered to CT
images using a mutual-information–based registration method.
FDG hyper-uptake volume (Vhyper) was obtained as the brain regions in the ipsilateral
hemisphere that exhibited a standardized uptake value (SUV) level greater than the mean
+2SD of that in the contralateral hemisphere from PET images that were taken 30 to 40
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minutes after FDG injection. In addition, Vhyper fraction (Fhyper) was calculated as the
Vhyper divided by the ipsilateral hemispheric volume. Similar criteria were applied on
autoradiography images to obtain volume with hyper-FDG uptake and Fhyper averaged from
3 sections was calculated for each animal.
Ischemic core volume was manually traced from each animal in the reperfusion subgroup
using the 24-hour T2w images. Volume measurements were obtained from 14 coronal slices
of the registered PET or MRI (from bregma +3.7 mm to bregma −7 mm and 0.775 mm per
slice) covering the MCA territory. Both the FDG hyper-uptake and ischemic core volumes
were overlaid onto the corresponding registered CBF and ADC maps acquired before PET
imaging of the same animal. Subsequently, the ratios of CBF and ADC in both the hyper-
uptake and the ischemic core regions to that of the homologous regions in the contralateral
hemisphere were obtained for different MCAO groups, respectively. To determine the extent
to which the FDG hyper-uptake regions were recruited into the infarction, an overlap
volume ratio (OVR) was calculated as the ratio of the overlap volume between Vhyper and
infraction to Vhyper.
Statistical Analysis
Data are presented as mean±SEM unless specified. Differences across groups were
compared using 1-way ANOVA for the Fhyper and SUV ratios. Multiple comparisons
between groups were made using the Bonferroni test. Normality test was passed for all data
sets. Pearson correlation analysis was performed using GraphPad Prism software. P<0.05
was considered significant.
Results
The exact time intervals between MCAO and FDG injection for the 5 groups were 30
minutes (35.6±7.1 minutes), 60 minutes (60.8±9.0 minutes), 90 minutes (88.2±4.9 minutes),
120 minutes (124.7±7.3 minutes), and 150 minutes (153.6±5.9 minutes), respectively.
Spatiotemporal dynamics of FDG uptake of a representative rat is shown in Figure 1. A
brain region with extremely low FDG uptake is clearly visible shortly after FDG injection,
most likely reflecting the ischemic core. An elevated FDG uptake region (arrows) becomes
visible 1200 s and more apparent 1800 s after FDG injection, which continues to increase
throughout the PET imaging session. Regardless of MCAO durations, averaged time uptake
curves (Figure 1, bottom) demonstrate that the hyper-uptake region always exhibits a lower
FDG uptake initially but continuously increases, surpasses normal tissue at around 10 to 20
minutes, and reaches significant differences at 30 to 40 minutes after injection.
The spatial characteristics of FDG uptake in relation to MCAO duration are shown in Figure
2. Evidently, a larger Vhyper is observed in animals with a shorter MCAO duration when
compared that with a longer MCAO duration (Figure 2A). Specifically, Fhyper is inversely
correlated with MCAO duration (Figure 2B; r=−0.62; P<0.001). Similarly, an inverse
relationship also exists between the SUV ratio of the hyper-uptake and normal-uptake
regions and the MCAO duration with an r of −0.46 (Figure 2C; P<0.05). Similar findings as
those using PET are also observed using autoradiography (Figure 3), where the Fhyper - is
inversely correlated with the MCAO duration (r=−0.45; P<0.05), further confirming the
validity of the PET findings.
The extent of ischemic injury in the hyper-FDG uptake regions was evaluated in the context
of ADC and CBF reduction (Figure 4). The ischemic core exhibits 71.9±1.0% and
32.5±0.7% reduction of CBF and ADC, respectively (averaged from animals in the
reperfusion subgroup), whereas the hyper-FDG uptake regions show 28.2±3.2% CBF and
9.1±1.4% ADC reductions (averaged from all animals), suggesting less severe ischemic
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injury in this region when compared with that in the ischemic core. In addition, the extent to
which ADC and CBF is reduced in both the hyper-FDG uptake regions and the ischemic
core seems independent of MCAO durations among the 5 groups (P>0.05).
The OVR (Figure 5) measured from animals in the reperfusion subgroup is small (Figure
5B) and statistically not different among groups (16.0±5%, 12.7±2.8%, 10.7±3.1%, and
9.1±2.9% for 30, 60, 90, and 120 minutes groups, respectively; P=0.55), leading to an
overall average OVR of 12.1±1.7% from all animals in the reperfusion subgroup. In
addition, the 24-hour T2 lesion, the Fhyper, and the overlap volumes (mm3) are provided in
the Figure II in the online-only Data Supplement. These results demonstrate that the
majority of the FDG hyper-uptake tissue was not recruited into 24-hour T2w lesion.
Additional boundary analysis to determine the spatial relation between regions of FDG
hyper-uptake and 24-hour T2 lesion is provided in Table I in the online-only Data
Supplement.
Discussion
Spatiotemporal dynamics of FDG uptakes during acute cerebral ischemia were evaluated in
a MCAO rat model. In addition to the anticipated reduction of FDG uptake in the ischemic
lesions, an elevated FDG uptake is present at the peri-ischemic regions, consistent with that
observed using autoradiography. The Fhyper inversely correlates with the duration of MCAO
(Figure 2), suggesting that the spatial extent of the observed elevated FDG uptake may be
modulated by the severity of ischemic injury. Temporally, independent of time interval
between MCAO and FDG injection, the SUV in the hyper-uptake regions surpasses the
normal brain area 10 to 20 minutes after FDG injection and persists throughout the
remaining PET imaging session (Figure 1). Mild reductions of CBF and ADC are found in
the hyper-uptake regions when compared with that in the contralateral hemisphere (Figure
4). More importantly, the majority of the hyper-FDG uptake volume is not recruited into
infarction in the reperfused animals (Figure 5), suggesting that the hyper-FDG uptake
regions may represent viable tissue that can be salvaged after reperfusion.
Although an increased accumulation of glucose around the ischemic border was first
reported by Ginsberg et al3 in 1977 using 2-deoxy- D-glucose in a 60-minute MCAO cat
model, this finding has not been consistently observed in subsequent reports by other
groups.8–10 We postulate that the discrepancy of time intervals between MCAO onset and
assessments of brain glucose metabolism among the reported studies can be the major factor
contributing to the inconsistent findings in the literature. Although our results suggest that
the hyper-FDG uptake at the peri-ischemic region is consistently observed between 30 and
150 minutes after MCAO, an inverse relation between Fhyper and time is observed. This
finding suggests that (1) beyond 150 minutes after MCAO, the volume of hyper-FDG
uptake is small and (2) imaging spatial resolution can be essential to delineate the presence
or the absence of hyper-FDG uptake. Specifically, a dedicated high-resolution animal PET
system was not available until recently. Therefore, it is conceivable that hyper-FDG uptake
in the peri-ischemic region was present, but the lack of dedicated small animal PET
prevented it from conclusively observed.
Several potential mechanisms may account for the observed hyper-uptake FDG in the peri-
ischemic zone. Using a permanent MCAO rat model and FDG PET, Schroeter et al17 found
increased glucose metabolism and concurrently increased neuroinflammation (PK-11195
PET) in the peri-ischemic regions 7 days after stroke. Similarly, Fukumoto et al18 reported
neuroinflammation-related hyper-FDG uptake 7 days after photothrombosis ischemia but
not before day 7. However, inflammation processes are unlikely to explain findings in our
study because PET images were obtained within 30 to 150 minutes after MCAO when
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significant neuroinflammation is not expected. The expression of glial fibrillary acidic
protein only starts to increase its mRNA 6 hours after occlusion in rats19 and transmigration
of blood-borne leukocytes is expected in more delayed phases of ischemic injury.
Alternatively, our results may suggest an elevated glycolysis at the peri-ischemic regions
during acute cerebral ischemia to compensate the loss of ATP. Lactate bioluminescence
imaging showed a higher lactate content in regions similar to the elevated FDG uptake area,
indicating glucolytic glucose metabolism in this area (Lactate bioluminescence imaging;
Figure III in the online-only Data Supplement). Whether this increased glucose metabolism
represents aerobic or anaerobic glycolysis is still under debate. Several early studies
attributed the increased glucose accumulation in the peri-ischemic region to anaerobic
glycolysis;20,21 however, other studies seem to argue against this conclusion. Wise et al5
conducted a serial PET study with measurements of both oxygen cerebral metabolic rate
(CMR) and cerebral glucose metabolic rate (CMRglu) in patients with stroke 1 to 31 days
after stroke. They found a lower oxygen extraction in the ischemic lesion, meaning adequate
oxygen supply, and the ratio of oxygen consumption and glucose metabolism was only one
third of that in normal brain tissue, indicating aerobic rather anaerobic glycolysis in
recovering ischemic tissue.5 In our study, only mild reduction of CBF was found in the
observed hyper-uptake regions, suggesting certain availability of oxygen in those regions,
and thus possible aerobic glycolysis, the conversion of glucose to lactate in the presence of
oxygen. Even though glycolysis is not energy efficient, it might be effective in protecting
cells from depolarizing because of its fast turn-around rate and its role as a membrane
energy provider.22 Therefore, it is possible that cells near the peri-ischemic zone use aerobic
glycolysis as the main energy production source to meet major cellular needs.
It is worth noting that elevated FDG uptake in the peri-ischemic region might not be
equivalent to increased glucose metabolism because of potential alteration of the lumped
constant (LC). The LC is the ratio between FDG and glucose metabolic rates, accounting for
differences of transportation, phosphorylation, and volume of distribution between these 2
compounds.23 Although Hawkins et al24 reported that there were no or very small LC
variations between ischemic and nonischemic tissues, more recent studies seem to suggest a
significant increase of the LC in ischemic or hypoperfused tissues, ranging from 20% to
78%.25,26 Additional studies will be needed to further determine whether regional LC
changes are present in the MCAO model used in our study.
The majority of the peri-ischemic regions exhibiting elevated FDG uptake seems to survive
in the reperfused animals (Figure 5), suggesting that acute PET imaging may offer insights
into tissue viability during cerebral ischemia. Specifically, a comprehensive study
determining the relation among CBF, CMRglu, ATP, and nicotinamide adenine dinucleotide
in a gerbil stroke model was conducted by Paschen et al.27 A 2-fold increase of CMRglu
above the normal level was observed for CBF between 20 and 35 mL/min per 100 g but
declined sharply for CBF <20 mL/min per 100 g. More importantly, the CBF threshold for
CMRglu reduction coincided with the initial ATP reduction as CBF decreased. Paschen et
al27 thus concluded that tissues with an increased CMRglu during acute cerebral ischemia
may represent penumbral tissues. Our findings seem highly consistent with that reported by
Paschen et al.27 In addition to the fact that only a small fraction of the hyper-uptake regions
was recruited into infarction, the inverse relation between Fhyper and the SUV ratio and the
MCAO duration is also consistent with the anticipated reduction of penumbral volume with
MCAO duration. Nevertheless, there are several fundamental methodological differences
between their and our studies. In particular, FDG uptake might not fully represent CMRglu.
Future studies focusing on the potential usage of CMRglu may be warranted.
Notice our experimental protocol, the FDG was given at a fixed time in relation to
reperfusion (40 minutes prior) independent of MCAO duration (Figure I in the online-only
Yuan et al. Page 6













Data Supplement). This experimental design most likely leads to the observed relatively
stable OVR across groups (Figure 5). A future alternative approach to further confirm our
current findings is to administer FDG at a fixed time in relation to the onset of MCAO, that
is, at 30 minutes after MCAO, followed by PET imaging, while varying the durations of
MCAO before reperfusion across different animals. In so doing, one would expect a positive
correlation between OVR and MCAO duration.
Our study also consists of 2 major shortcomings. First, it has been demonstrated that infract
volume may continue to grow beyond the first 24 hours after reperfusion,28 raising a
question as to whether 24-hour T2w lesion reflects the final infarction. To address this
question, a pilot study (n=5) was conducted where T2 lesion was assessed in the same
animals 24 and 48 hours after reperfusion. Although our result shows a small increase of T2
lesion volume, 5.1±1.8%, from 24 to 48 hours after MCAO (Figure IV in the online-only
Data Supplement), it should be noted that continuing lesion growth may be present. Second,
brain swelling resulting from brain edema may be present in the 24-hour T2w images,
leading to potential confounds when acute PET images were registered with the 24-hour
T2w images using rigid registration algorithms. Correcting the effects of edema using
approaches proposed by either Leach et al29 or Swanson et al30 may not be effective for the
spatial overlay analysis used in this study because these methods rely on volume comparison
between the 2 hemispheres. A more appropriate method may be the deformable registration
approach. However, deformable registration for MR and PET is complex and the accuracy
of different deformable registration approaches in animals is yet to be determined.
In conclusion, spatiotemporal characteristics of FDG uptake in an acute MCAO ischemic
stroke rat model were revealed. In addition to the well anticipated reduction of FDG uptake
in the ischemic lesions, hyper-FDG uptake at the peri-ischemic regions is consistently
observed. This hyper-FDG uptake area may represent viable tissue because most of the
hyper-uptake regions were not recruited into the infarction. Future work will focus on
validating whether the region of hyper-FDG uptake is indeed ischemia penumbra by further
extending MCAO >150 minutes and including a permanent occlusion model. Considering
the wide availability of FDG PET imaging capability in most of the medical centers, our
results underscore the potential clinical usage of FDG PET in the management of patients
with acute stroke.
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Top, Coregistered cerebral blood flow (CBF) and apparent diffusion coefficient (ADC)
maps superimposed on the computed tomographic (CT) images, and dynamic positron
emission tomographic (PET) images from a rat with [18]F-2-fluoro-2-deoxy-D-glucose
(FDG) injected at 58 min after middle cerebral artery occlusion. Temporal and spatial FDG
uptake distributions before (0 s) and after FDG injection (30–2400 s) are shown. Diminished
FDG uptake in the right side of the brain indicates the ischemic lesion. Hyper-uptake of
FDG (arrows) is clearly visible in the peri-ischemic region at 30 and 40 min. Dynamic
uptake curves from a cortical region in the contralateral hemisphere (dashed lines) and peri-
ischemic region (solid lines) are shown in the bottom. The peri-ischemic region was defined
from the last PET frame showing elevated FDG uptake. FDG uptake in the peri-ischemic
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region at 30 to 40 min after the injection was significantly higher than that in the
contralateral hemisphere (**P<0.01; *P<0.05). SUV indicates standardized uptake value.
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A, [18]F-2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomographic (PET) images
obtained from a control animal and a representative middle cerebral artery occlusion
(MCAO) animal from each group with varied MCAO durations. PET images are overlaid on
computed tomographic images. Scatter plots of hyper-uptake volume fraction (Fhyper; B)
and standardized uptake value (SUV) ratios (C) reveal an inverse relation with MCAO
duration. The dotted lines are the fitted linear regression lines.
Yuan et al. Page 12














High-resolution autoradiography images from a control and 4 representative middle cerebral
artery occlusion (MCAO) rats demonstrate [18]F-2-fluoro-2-deoxy-D-glucose (FDG)
distribution in relation to MCAO duration. Time on the upper left corner of each image is
the time interval between MCAO and FDG injection. The hyper-uptake volume fraction
reduces as MCAO duration increases. The dotted line is the fitted linear regression line.
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A, Registered positron emission tomographic (PET)/computed tomographic, cerebral blood
flow (CBF), and apparent diffusion coefficient (ADC) maps from a representative animal
with [18]F-2-fluoro-2-deoxy-D-glucose (FDG) injected at 120 min after middle cerebral
artery occlusion (MCAO). Dotted lines indicate the regions with hyper-FDG uptake. The
CBF (B) and ADC (C) ratios of the hyper-uptake tissue (□) or the ischemic core (▪) to the
contralateral region are shown for different MCAO groups, respectively. Boxes indicate
75th and 25th percentile levels.
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Colocalization analysis on hyper-uptake and 24-h T2 lesion. A, An example of registered
[18]F-2-fluoro-2-deoxy-D-glucose (FDG) positron emission tomographic (PET)/computed
tomographic (CT) and 24-h T2-weighted (T2w) images of a rat with FDG injected at 60 min
after middle cerebral artery occlusion (MCAO) is shown (bregma +1.1 mm). The hyper-
uptake region is marked by the dashed lines, whereas the 24-h T2 lesion is demarcated in
yellow line. The overlap volume ratio (B) was measured from 14 coronal slides of registered
images. Bars indicate mean overlap ratios for each group. No significant difference was
found among the 4 groups.
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